cilostazol has been researched along with Demyelinating Diseases in 1 studies
Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Co-treatment with cilostazol prevented paclitaxel-induced dedifferentiation of Schwann cell cultures and demyelination in a mixed culture of Schwann cells and dorsal root ganglia neurons." | 1.62 | Cilostazol is an effective causal therapy for preventing paclitaxel-induced peripheral neuropathy by suppression of Schwann cell dedifferentiation. ( Imai, S; Iwamitsu, Y; Koyanagi, M; Matsubara, K; Matsumoto, M; Moriya, A; Nakagawa, S; Nakagawa, T; Nakazato, Y; Ogihara, T; Saigo, M; Yonezawa, A, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koyanagi, M | 1 |
| Imai, S | 1 |
| Iwamitsu, Y | 1 |
| Matsumoto, M | 1 |
| Saigo, M | 1 |
| Moriya, A | 1 |
| Ogihara, T | 1 |
| Nakazato, Y | 1 |
| Yonezawa, A | 1 |
| Nakagawa, S | 1 |
| Nakagawa, T | 1 |
| Matsubara, K | 1 |
1 other study available for cilostazol and Demyelinating Diseases
| Article | Year |
|---|---|
Cilostazol is an effective causal therapy for preventing paclitaxel-induced peripheral neuropathy by suppression of Schwann cell dedifferentiation.
Topics: Animals; Blood Proteins; Breast Neoplasms; Cell Dedifferentiation; Cell Line, Tumor; Cilostazol; Dem | 2021 |